Increased neutrophil migration in smokers with or without chronic obstructive pulmonary disease

Respirology

Volumn 17, Issue 5, 2012, Pages 854-860

  Blidberg, Kristin ^a   Palmberg, Lena ^a   Dahlén, Barbro ^b   Lantz, Ann Sofie ^b   Larsson, Kjell ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

chemotaxis; chronic obstructive pulmonary disease; interleukin 8; leukotriene B4; neutrophil

Indexed keywords

CD11B ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; LEUKOTRIENE B4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING;

AGED; CASE-CONTROL STUDIES; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOTRIENE B4; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862999903     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02181.x     Document Type: Article

References (36)

1. Murray CJ, Lopez AD,. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504. (Pubitemid 27216360)
2. Buist AS, McBurnie MA, Vollmer WM, et al,. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50. (Pubitemid 47321907)
3. Larsson K,. Aspects on pathophysiological mechanisms in COPD. J. Intern. Med. 2007; 262: 311-40. (Pubitemid 47246974)
4. Barnes PJ,. Mediators of chronic obstructive pulmonary disease. Pharmacol. Rev. 2004; 56: 515-48. (Pubitemid 39658462)
5. Tager AM, Luster AD,. BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot. Essent. Fatty Acids 2003; 69: 123-34.
6. Ye RD, Boulay F, Wang JM, et al,. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009; 61: 119-61.
7. Di Stefano A, Capelli A, Lusuardi M, et al,. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 1998; 158: 1277-85. (Pubitemid 28489033)
8. Keatings VM, Collins PD, Scott DM, et al,. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 1996; 153: 530-4.
9. Pesci A, Balbi B, Majori M, et al,. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur. Respir. J. 1998; 12: 380-6. (Pubitemid 28389533)
10. Kostikas K, Gaga M, Papatheodorou G, et al,. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127: 1553-9. (Pubitemid 46218778)
11. Woolhouse IS, Bayley DL, Stockley RA,. Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax 2002; 57: 709-14. (Pubitemid 34864528)
12. Beeh KM, Kornmann O, Buhl R, et al,. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 2003; 123: 1240-7. (Pubitemid 36444384)
13. Patel IS, Seemungal TA, Wilks M, et al,. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-64. (Pubitemid 34984972)
14. Ras G, Wilson R, Todd H, et al,. Effect of bacterial products on neutrophil migration in vitro. Thorax 1990; 45: 276-80. (Pubitemid 20143763)
15. Noguera A, Batle S, Miralles C, et al,. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001; 56: 432-7. (Pubitemid 32521359)
16. Montuschi P, Peters-Golden ML,. Leukotriene modifiers for asthma treatment. Clin. Exp. Allergy 2010; 40: 1732-41.
17. American Thoracic Society. Standardization of spirometry, 1994 update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-36.
18. Frevert CW, Wong VA, Goodman RB, et al,. Rapid fluorescence-based measurement of neutrophil migration in vitro. J. Immunol. Methods 1998; 213: 41-52. (Pubitemid 28376594)
19. Condliffe AM, Kitchen E, Chilvers ER,. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin. Sci. 1998; 94: 461-71. (Pubitemid 28205909)
20. Drost EM, MacNee W,. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur. J. Immunol. 2002; 32: 393-403. (Pubitemid 34173331)
21. Bajaj MS, Kew RR, Webster RO, et al,. Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe. Inflammation 1992; 16: 241-50.
22. Larsson L, Szponar B, Pehrson C,. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air 2004; 14: 421-4. (Pubitemid 39523854)
23. Tanni SE, Pelegrino NR, Angeleli AY, et al,. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J. Inflamm. 2010; 7: 29.
24. Anderson R, Theron AJ, Richards GA, et al,. Passive smoking by humans sensitizes circulating neutrophils. Am. Rev. Respir. Dis. 1991; 144: 570-4.
25. Nowak D, Ruta U, Piasecka G,. Nicotine increases human polymorphonuclear leukocytes chemotactic response-a possible additional mechanism of lung injury in cigarette smokers. Exp. Pathol. 1990; 39: 37-43. (Pubitemid 20182881)
26. Meyer JD, Yurt RW, Duhaney R, et al,. Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils. Arch. Surg. 1988; 123: 1454-8.
27. Asagoe K, Yamamoto K, Takahashi A, et al,. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. J. Immunol. 1998; 160: 4518-25. (Pubitemid 28217311)
28. Khandaker MH, Mitchell G, Xu L, et al,. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 1999; 93: 2173-85. (Pubitemid 29153617)
29. Fan J, Malik AB,. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat. Med. 2003; 9: 315-21. (Pubitemid 36362787)
30. Strandberg K, Blidberg K, Sahlander K, et al,. Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils. Pulm. Pharmacol. Ther. 2010; 23: 316-23.
31. Sadowska AM, Manuel-y-Keenoy B, De Backer WA,. Inhibition of in vitro neutrophil migration through a bilayer of endothelial and epithelial cells using beta2-agonists: concomitant effects on IL-8 and elastase secretion and impact of glucocorticosteroids. Pulm. Pharmacol. Ther. 2005; 18: 354-62. (Pubitemid 40804533)
32. Bowden JJ, Sulakvelidze I, McDonald DM,. Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol. J. Appl. Physiol. 1994; 77: 397-405. (Pubitemid 24226160)
33. Vacca G, Randerath WJ, Gillissen A,. Inhibition of granulocyte migration by tiotropium bromide. Respir. Res. 2011; 12: 24.
34. Yoshikawa T, Dent G, Ward J, et al,. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 175: 473-9. (Pubitemid 46354251)
35. Burnett D, Chamba A, Hill SL, et al,. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 1987; 2: 1043-6. (Pubitemid 17154783)
36. Stockley RA, Grant RA, Llewellyn-Jones CG, et al,. Neutrophil formyl-peptide receptors. Relationship to peptide-induced responses and emphysema. Am. J. Respir. Crit. Care Med. 1994; 149: 464-8. (Pubitemid 24068997)